Quick Answer
HCW Biologics Inc. reported Research And Development Expense of $5.44 million for the year ending 2025.
- HCW Biologics Inc. showed a decrease of -14.8% in Research And Development Expense from 2024 to 2025.
- This data is from HCW Biologics Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), HCW Biologics Inc.'s Research And Development Expense has declined by 25.0%.
- Historical annual values: Fiscal year 2025: $5.44 million | Fiscal year 2024: $6.39 million | Fiscal year 2023: $7.68 million | Fiscal year 2022: $9.34 million | Fiscal year 2021: $8.17 million | Fiscal year 2020: $7.26 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: